EyePoint Pharmaceuticals

SEC Filings

Form Description Filing date View
10-KT

Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
5

Annual filing director officer or owner of more than ten percent.

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
EyePoint Pharmaceuticals